ACE2 and COVID-19: Of note, plasma levels of ACE2 and Ang II do not correlate with the clinical outcomes in patients with COVID-19 (24); thus, the concentration of Ang II in the circulation is not a reliable indicator of its local concentration in the lower airways where Ang II-induced vasoconstriction may reduce the pulmonary microcirculation.